EP1171460A4 - 48 proteines secretees humaines - Google Patents

48 proteines secretees humaines

Info

Publication number
EP1171460A4
EP1171460A4 EP00920139A EP00920139A EP1171460A4 EP 1171460 A4 EP1171460 A4 EP 1171460A4 EP 00920139 A EP00920139 A EP 00920139A EP 00920139 A EP00920139 A EP 00920139A EP 1171460 A4 EP1171460 A4 EP 1171460A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00920139A
Other languages
German (de)
English (en)
Other versions
EP1171460A1 (fr
Inventor
Craig A Rosen
Steven M Ruben
George Komatsoulis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1171460A1 publication Critical patent/EP1171460A1/fr
Publication of EP1171460A4 publication Critical patent/EP1171460A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP00920139A 1999-04-09 2000-04-06 48 proteines secretees humaines Withdrawn EP1171460A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12870099P 1999-04-09 1999-04-09
US128700P 1999-04-09
US17693000P 2000-01-20 2000-01-20
US176930P 2000-01-20
PCT/US2000/008980 WO2000061624A1 (fr) 1999-04-09 2000-04-06 48 proteines secretees humaines

Publications (2)

Publication Number Publication Date
EP1171460A1 EP1171460A1 (fr) 2002-01-16
EP1171460A4 true EP1171460A4 (fr) 2002-10-09

Family

ID=26826863

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00920139A Withdrawn EP1171460A4 (fr) 1999-04-09 2000-04-06 48 proteines secretees humaines

Country Status (5)

Country Link
EP (1) EP1171460A4 (fr)
JP (1) JP2003500017A (fr)
AU (1) AU4072100A (fr)
CA (1) CA2365522A1 (fr)
WO (1) WO2000061624A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002238483A1 (en) * 2001-01-03 2002-07-16 Bayer Aktiengesellschaft Regulation of human ornithine decarboxylase
JP2004535794A (ja) 2001-05-03 2004-12-02 チルドレンズ・メディカル・センター・コーポレイション 精子特異的カチオンチャネルおよびその使用
AU2002364939A1 (en) * 2001-10-22 2003-07-09 Board Of Regents, The University Of Texas System Sperm-specific cation channel, catsper2, and uses therefor
US8729248B2 (en) 2001-10-22 2014-05-20 Children's Medical Center Corporation Sperm-specific cation channel, CATSPER2, and uses therefor
WO2004015066A2 (fr) 2002-08-07 2004-02-19 Children's Medical Center Corporation Canal cationique specifique au sperme, catsper-4, et utilisations
WO2004015067A2 (fr) 2002-08-07 2004-02-19 Children's Medical Center Corporation Canal cationique specifique du sperme, catsper-3, et utilisations correspondantes
WO2013171595A1 (fr) 2012-05-16 2013-11-21 Ramot At Tel-Aviv University Ltd. Nouveaux composés et procédés pour l'inhibition de la mort cellulaire

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
WO1998046756A1 (fr) * 1997-04-16 1998-10-22 Millennium Biotherapeutics Compositions de proteines secretees ssp-1 et utilisations de ces compositions a des fins diagnostiques et therapeutiques

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
WO1998046756A1 (fr) * 1997-04-16 1998-10-22 Millennium Biotherapeutics Compositions de proteines secretees ssp-1 et utilisations de ces compositions a des fins diagnostiques et therapeutiques

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] EMBL; 14 July 1998 (1998-07-14), ADAMS ET AL.: "Use of a random BAC End Sequence Database for Sequence-Ready Map Building (1998)", XP002198848, retrieved from EBI Database accession no. AQ044764 *
HILLIER AT AL: "Generation and analysis of 280,000 human expressed sequence tags", GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, US, vol. 9, no. 6, September 1996 (1996-09-01), pages 807 - 828, XP000914615, ISSN: 1088-9051 *
KATO S ET AL: "Construction of a human full-length cDNA bank", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 150, 1994, pages 243 - 250, XP002081364, ISSN: 0378-1119 *
See also references of WO0061624A1 *

Also Published As

Publication number Publication date
AU4072100A (en) 2000-11-14
JP2003500017A (ja) 2003-01-07
EP1171460A1 (fr) 2002-01-16
WO2000061624A8 (fr) 2001-03-08
CA2365522A1 (fr) 2000-10-19
WO2000061624A1 (fr) 2000-10-19

Similar Documents

Publication Publication Date Title
EP1218408A4 (fr) 32 proteines humaines secretees
EP1212343A4 (fr) 52 proteines humaines secretees
EP1181390A4 (fr) 27 proteines humaines secretees
EP1224285A4 (fr) 27 proteines humaines secretees
EP1212342A4 (fr) 18 proteines secretees humaines
EP1226231A4 (fr) 19 proteines humaines secretees
EP1175438A4 (fr) Soixante-deux prot ines humaines s cr t es
EP1192176A4 (fr) 49 proteines secretees humaines
EP1192278A4 (fr) 48 proteines secretees humaines
EP1165827A4 (fr) 45 proteines humaines secretees
EP1175439A4 (fr) 49 proteines humaines secretees
EP1159284A4 (fr) 33 proteines humaines secretees
EP1189917A4 (fr) 48 proteines humaines secretees
EP1185543A4 (fr) 50 proteines humaines secretees
EP1173477A4 (fr) 49 proteines humaines secretees
EP1224201A4 (fr) 32 proteines humaines secretees
EP1203005A4 (fr) 25 proteines secretees humaines
EP1206573A4 (fr) 26 proteines humaines secretees
EP1144614A4 (fr) Proteines humaines secretees (33)
EP1171460A4 (fr) 48 proteines secretees humaines
EP1169332A4 (fr) Proteines humaines secretees (49)
EP1165602A4 (fr) 49 proteines secretees par un etre humain
EP1165828A4 (fr) 50 proteines humaines secretees
EP1228082A4 (fr) Proteines humaines secretees 29
EP1185285A4 (fr) 49 proteines secretees humaines

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011105

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20020827

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20040505